ISLB 2021 | Impact of COVID-19 on lung cancer diagnosis and treatment

Amy Moore, PhD, LUNGevity Foundation, San Carlos, CA, discusses the impact that COVID-19 has had on lung cancer treatment and research. Patients with lung cancer have a higher risk of mortality from COVID-19, and were prioritised for vaccines. Additionally, many people missed routine screening during the pandemic which meant that early diagnosis of lung cancer was much more difficult. Dr Moore also discusses initiatives to improve telehealth access and reform clinical trials, to make effective treatment accessible to as many patients as possible. This interview took place at the International Society of Liquid Biopsy (ISLB) 2021 Virtual Meeting.